SG11202103851PA - Dry pharmaceutical composition for inhalation - Google Patents
Dry pharmaceutical composition for inhalationInfo
- Publication number
- SG11202103851PA SG11202103851PA SG11202103851PA SG11202103851PA SG11202103851PA SG 11202103851P A SG11202103851P A SG 11202103851PA SG 11202103851P A SG11202103851P A SG 11202103851PA SG 11202103851P A SG11202103851P A SG 11202103851PA SG 11202103851P A SG11202103851P A SG 11202103851PA
- Authority
- SG
- Singapore
- Prior art keywords
- inhalation
- pharmaceutical composition
- dry pharmaceutical
- dry
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18201253 | 2018-10-18 | ||
PCT/EP2019/078277 WO2020079185A1 (en) | 2018-10-18 | 2019-10-17 | Dry pharmaceutical composition for inhalation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202103851PA true SG11202103851PA (en) | 2021-05-28 |
Family
ID=64023943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202103851PA SG11202103851PA (en) | 2018-10-18 | 2019-10-17 | Dry pharmaceutical composition for inhalation |
Country Status (7)
Country | Link |
---|---|
US (1) | US20210338575A1 (en) |
EP (1) | EP3866756A1 (en) |
JP (1) | JP2022505318A (en) |
KR (1) | KR20210079319A (en) |
CN (1) | CN113056258A (en) |
SG (1) | SG11202103851PA (en) |
WO (1) | WO2020079185A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114948975A (en) * | 2022-06-08 | 2022-08-30 | 郭雅图 | Application of monophosphoryl lipid A in preparation of medicine for treating adult amblyopia |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
WO2010003465A2 (en) | 2008-07-11 | 2010-01-14 | Universita' Degli Studi Di Parma | A drug powder for inhalation administration and a process thereof |
EP2199301A1 (en) | 2008-12-19 | 2010-06-23 | DKFZ Deutsches Krebsforschungszentrum | Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or fragment thereof |
BRPI1013895B1 (en) * | 2009-04-10 | 2021-08-03 | The Johns Hopkins University | VIRUS-LIKE PARTICLE COMPOSITIONS (VLP) OF PAPILOMA AND CAPSOMERAL VIRUSES, METHOD OF PREPARATION THEREOF, VACCINE COMPRISING SUCH VLP COMPOSITION, CHIMERIC POLYPEPTIDE, KIT COMPRISING VLP REVERSE COMPOSITION, REFERRED TO WITH USES |
ES2687288T3 (en) * | 2012-03-02 | 2018-10-24 | Institut National De La Santé Et De La Recherche Médicale (Inserm) | Use of a tetrafunctional non-ionic amphiphilic block copolymer modified by glycosylation as an immune adjuvant |
JP6375289B2 (en) * | 2012-04-05 | 2018-08-15 | マサチューセッツ インスティテュート オブ テクノロジー | Immune stimulating composition and method of use thereof |
BR122019026637B1 (en) * | 2013-07-18 | 2023-09-26 | Mannkind Corporation | PHARMACEUTICAL DRY POWDER FORMULATIONS AND METHOD FOR MANUFACTURING A DRY POWDER FORMULATION |
JP6792294B2 (en) * | 2015-05-29 | 2020-11-25 | ダイナバックス テクノロジーズ コーポレイション | Intrapulmonary administration of Toll-like receptor 9 agonists of polynucleotides for treating lung cancer |
CN108350070B (en) * | 2015-09-09 | 2022-01-28 | 诺华股份有限公司 | Thymic Stromal Lymphopoietin (TSLP) -binding molecules and methods of use thereof |
WO2017211886A1 (en) | 2016-06-07 | 2017-12-14 | Deutsches Krebsforschungszentrum | Improvement of hpv l2 peptide immunogenicity |
-
2019
- 2019-10-17 CN CN201980068364.4A patent/CN113056258A/en active Pending
- 2019-10-17 WO PCT/EP2019/078277 patent/WO2020079185A1/en unknown
- 2019-10-17 JP JP2021521291A patent/JP2022505318A/en active Pending
- 2019-10-17 SG SG11202103851PA patent/SG11202103851PA/en unknown
- 2019-10-17 EP EP19786610.6A patent/EP3866756A1/en active Pending
- 2019-10-17 US US17/286,293 patent/US20210338575A1/en active Pending
- 2019-10-17 KR KR1020217014818A patent/KR20210079319A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20210338575A1 (en) | 2021-11-04 |
EP3866756A1 (en) | 2021-08-25 |
CN113056258A (en) | 2021-06-29 |
WO2020079185A1 (en) | 2020-04-23 |
JP2022505318A (en) | 2022-01-14 |
KR20210079319A (en) | 2021-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202011761XA (en) | Nicotine formulation | |
ZA201906613B (en) | Pharmaceutical compositions for combination therapy | |
ZA201905510B (en) | Pharmaceutical compositions for combination therapy | |
PL3107548T3 (en) | Dry powder formulations for inhalation | |
GB201712159D0 (en) | Pharmaceutical composition | |
ZA202006570B (en) | Pharmaceutical formulations | |
GB201911517D0 (en) | Pharmaceutical composition | |
GB201804548D0 (en) | Pharmaceutical compositions | |
PL3179986T3 (en) | Dry powder formulations for inhalation | |
EP3375443A4 (en) | Pharmaceutical composition for treating respiratory diseases | |
GB201807053D0 (en) | Pharmaceutical composition | |
SG11202103374TA (en) | Pharmaceutical composition | |
IL268708B (en) | Pharmaceutical compositions for combination therapy | |
PL3621682T3 (en) | Dry powder inhaler | |
EP3727485C0 (en) | Pharmaceutical composition | |
PT3632436T (en) | Pharmaceutical composition comprising lenvatinib salts | |
SG11202103851PA (en) | Dry pharmaceutical composition for inhalation | |
GB201808571D0 (en) | Pharmaceutical compositions | |
EP3485888A4 (en) | Medicinal composition for inhalation | |
EP3463378A4 (en) | Dry powder formulations for inhalation | |
SG11202110315SA (en) | Pharmaceutical composition | |
FI3908321T3 (en) | Pharmaceutical composition | |
SG11202010792TA (en) | Improved pharmaceutical formulations | |
PT3650024T (en) | Pharmaceutical composition for nasal administration | |
GB201808567D0 (en) | Pharmaceutical compositions |